The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These groundbreaking therapies represent a https://ianficp215632.bimmwiki.com/11415864/glp_3_receptor_agonists_retatrutide_trizepatide